Skip to main content
SpringerLink
Log in

Is Two Better Than One? Combining Antiresorptive and Anabolic Osteoporosis Medications

  • Clinical Trial Report
  • Published:
Current Osteoporosis Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boonen S, Marin F, Obermayer-Pietsch B, Simoes ME, Barker C, Glass EV, et al. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2008;93(3):852–60.

    Article  PubMed  CAS  Google Scholar 

  2. Cosman F, Nieves J, Zion M, Woelfert L, Luckey M, Lindsay R. Daily and cyclic parathyroid hormone in women receiving alendronate. N Engl J Med. 2005;353(6):566–75.

    Article  PubMed  CAS  Google Scholar 

  3. Ettinger B, San Martin J, Crans G, Pavo I. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J Bone Miner Res. 2004;19(5):745–51.

    Article  PubMed  CAS  Google Scholar 

  4. Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, et al. Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab. 2008;93(10):3785–93.

    Article  PubMed  CAS  Google Scholar 

  5. Gasser JA, Kneissel M, Thomsen JS, Mosekilde L. PTH and interactions with bisphosphonates. J Musculoskelet Neuronal Interact. 2000;1(1):53–6.

    PubMed  CAS  Google Scholar 

  6. Foster S, Foley K, Meadows E, Johnston J, Wang S, Pohl G, et al. Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance. Osteoporos Int. 2011;22(2):551–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, University of Alabama at Birmingham, RPHB 523C, Birmingham, AL, 35294, USA

    Nicole C. Wright

  2. Division of Rheumatology and Immunology, University of Alabama at Birmingham, FOT 820, Birmingham, AL, 35294, USA

    Kenneth G. Saag

Authors
  1. Nicole C. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth G. Saag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicole C. Wright.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wright, N.C., Saag, K.G. Is Two Better Than One? Combining Antiresorptive and Anabolic Osteoporosis Medications. Curr Osteoporos Rep 9, 109–111 (2011). https://doi.org/10.1007/s11914-011-0057-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11914-011-0057-0

Keywords

Search

Navigation